Portal de Periódicos da CAPES

p53, Bcl‐2, PCNA Expression, and Apoptotic Rates during Cervical Tumorigenesis

2003; Wiley; Volume: 1010; Issue: 1 Linguagem: Inglês

10.1196/annals.1299.138

1749-6632

Horacio Astudillo, TEZCATLIPOCA LOPEZ, Sebastián Castillo, Patricio Gariglio, L. Gutiérrez Benítez,

Endometrial and Cervical Cancer Treatments

Annals of the New York Academy of SciencesVolume 1010, Issue 1 p. 771-774 p53, Bcl-2, PCNA Expression, and Apoptotic Rates during Cervical Tumorigenesis HORACIO ASTUDILLO, Corresponding Author HORACIO ASTUDILLO Unidad de Investigacion Medica en Enfermedades Oncologicas, Hospital de Oncologia, CMN Siglo XXI, IMSS, CP 06720, Mexico Programa de Biomedicina Molecular ENMyH-IPN, CINVESTAV-IPN, MexicoAddress for correspondence: Dr. Horacio Astudillo, Unidad de Investigacion Medica en Enfermedades Oncologicas, Hospital de Oncologia, CMN Siglo XXI, IMSS, CP 06720, Mexico. Voice: 525-56276900, ext. 4318. [email protected]Search for more papers by this authorTEZCATLIPOCA LOPEZ, TEZCATLIPOCA LOPEZ Unidad de Investigacion Medica en Enfermedades Oncologicas, Hospital de Oncologia, CMN Siglo XXI, IMSS, CP 06720, MexicoSearch for more papers by this authorSEBASTIAN CASTILLO, SEBASTIAN CASTILLO Unidad de Investigacion Medica en Enfermedades Oncologicas, Hospital de Oncologia, CMN Siglo XXI, IMSS, CP 06720, MexicoSearch for more papers by this authorPATRICIO GARIGLIO, PATRICIO GARIGLIO Departamento de Genetica y Biologia Molecular, CINVESTAV-IPN, MexicoSearch for more papers by this authorLUIS BENITEZ, LUIS BENITEZ Unidad de Investigacion Medica en Enfermedades Oncologicas, Hospital de Oncologia, CMN Siglo XXI, IMSS, CP 06720, MexicoSearch for more papers by this author HORACIO ASTUDILLO, Corresponding Author HORACIO ASTUDILLO Unidad de Investigacion Medica en Enfermedades Oncologicas, Hospital de Oncologia, CMN Siglo XXI, IMSS, CP 06720, Mexico Programa de Biomedicina Molecular ENMyH-IPN, CINVESTAV-IPN, MexicoAddress for correspondence: Dr. Horacio Astudillo, Unidad de Investigacion Medica en Enfermedades Oncologicas, Hospital de Oncologia, CMN Siglo XXI, IMSS, CP 06720, Mexico. Voice: 525-56276900, ext. 4318. [email protected]Search for more papers by this authorTEZCATLIPOCA LOPEZ, TEZCATLIPOCA LOPEZ Unidad de Investigacion Medica en Enfermedades Oncologicas, Hospital de Oncologia, CMN Siglo XXI, IMSS, CP 06720, MexicoSearch for more papers by this authorSEBASTIAN CASTILLO, SEBASTIAN CASTILLO Unidad de Investigacion Medica en Enfermedades Oncologicas, Hospital de Oncologia, CMN Siglo XXI, IMSS, CP 06720, MexicoSearch for more papers by this authorPATRICIO GARIGLIO, PATRICIO GARIGLIO Departamento de Genetica y Biologia Molecular, CINVESTAV-IPN, MexicoSearch for more papers by this authorLUIS BENITEZ, LUIS BENITEZ Unidad de Investigacion Medica en Enfermedades Oncologicas, Hospital de Oncologia, CMN Siglo XXI, IMSS, CP 06720, MexicoSearch for more papers by this author First published: 24 January 2006 https://doi.org/10.1196/annals.1299.138Citations: 16Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Citing Literature Volume1010, Issue1Apoptosis from Signaling Pathways to Therapeutic ToolsDecember 2003Pages 771-774 RelatedInformation